Tag : Biomarker

Dermatology

Diabetes leads to drastic reduction in the kidney's potential to clean itself

Newsemia
The kidneys often become bulky and dysfunctional in diabetes, and now scientists have found that one path to this damage dramatically reduces the kidney’s ability...
Surgery/Cosmetic

HSS Researchers Launch Study Using Novel MRI Techniques to Find a Biomarker for Parsonage-Turner Syndrome, A Nerve Disorder

Newsemia
Researchers at Hospital for Special Surgery (HSS) are using a novel MRI technique known as magnetic resonance neurography, or MRN, to study Parsonage-Turner Syndrome (PTS),...
Cardiology

BIOMARKER SST2 AS AN EARLY PREDICTOR OF ACUTE RENAL INJURY IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION.

Newsemia
Related Articles BIOMARKER SST2 AS AN EARLY PREDICTOR OF ACUTE RENAL INJURY IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION. Georgian Med News. 2020 May;(302):53-58...
Neurology

ECG Promising for Predicting Major Depression, Treatment Response

Newsemia
The resting heart rate of patients with major depression may offer clues as to how well they will respond to antidepressant therapy, and may even...
Cardiology

IL-19 as a Biomarker for the Severity of Acute Myocardial Infarction.

Newsemia
Related Articles IL-19 as a Biomarker for the Severity of Acute Myocardial Infarction. Arch Med Res. 2020 02;51(2):160-166 Authors: Qi L, Zhang J, Wu K,...
Gastroenterology

A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis

Newsemia
A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis Source link...
Neurology

ECNP 2020

Newsemia
Read clinically focused news coverage of key developments from ECNP 2020. Medscape Psychiatry Source link...
Neurology

High Plasma GFAP Level Predicts Disability in Progressive MS

Newsemia
A high level of glial fibrillary acidic protein (GFAP) in the blood may predict worsening disability in patients with secondary progressive multiple sclerosis (MS), according...
Neurology

NfL Blood Biomarker Captures Suboptimal Treatment Response in MS

Newsemia
Measuring levels of neurofilament light chain is an effective way of detecting disease activity and the need to optimize treatment in patients with multiple sclerosis,...
Neurology

App for MS Aims to Capture Elusive Signals of Progression

Newsemia
Investigators in Switzerland are testing an application for smartphones that they hope will elucidate subtle signs of disease progression in multiple sclerosis (MS) — beyond...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World